Key developments in pancreatic cancer from ESMO 2019
Key developments in pancreatic cancer from ESMO 2019
Radiotherapy for liver cancer, and neoadjuvant therapy for rectal cancer
Applied precision cancer medicine in advanced biliary tract cancer
Treating HER2-mutant advanced biliary tract cancer with neratinib
Latest advances in pancreatic cancer treatment and impact on practice
Implementing national cancer control plans
Comment: POLO III trial for metastatic pancreatic cancer
Comment: Laparoscopic versus open resection for colorectal liver metastases
ABC-06 results: Second-line ASC mFOLFOX chemotherapy for biliary tract cancer
Managing metastatic breast cancer and beyond using PARP inhibitors
POLO Trial: Olaparib as a maintenance treatment following first-line chemotherapy in patients with metastatic pancreatic cancer
Highlights from ASCO 2019